Wagener, R. (2018). IG-MYC+ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas. American Society of Hematology (ASH).
Chicago Style (17th ed.) CitationWagener, R. IG-MYC+ Neoplasms with Precursor B-cell Phenotype Are Molecularly Distinct from Burkitt Lymphomas. American Society of Hematology (ASH), 2018.
MLA (9th ed.) CitationWagener, R. IG-MYC+ Neoplasms with Precursor B-cell Phenotype Are Molecularly Distinct from Burkitt Lymphomas. American Society of Hematology (ASH), 2018.
Warning: These citations may not always be 100% accurate.